News Releases
Cannabix Technologies Develops Beta Version of Cannabix Marijuana Breathalyzer
July 25, 2016
Vancouver, British Columbia, July 25, 2016 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) provides an update on the Company’s efforts on development of its FAIMS (high-field asymmetric waveform ion mobility spectrometry) Cannabix Marijuana Breathalyzer based instrument for detection of trace amounts of Tetrahydrocannabinol (“THC”). The Company is pleased to report that it has developed a stand-alone desktop sized “Beta 1.0” device with a proprietary configurable high voltage power supply which operates on conventional power sources. Preliminary lab tests of the FAIMS device coupled with conventional quadrupole mass spectrometry have shown similar levels of detection for THC standards.
The FAIMS cell employed in this device is 4X smaller than the prior benchtop version and has a 10X reduction in power supply requirements, which allows a drastically smaller footprint. The current power supply is readily configurable for ongoing testing and is designed to integrate with the non-radioactive ionization source and soon to be implemented customized detector. The Company expects to complete a “Beta 2.0” device that will be prepared for external testing. With ongoing technical advances, the company is rapidly reducing the size of each internal component and is improving the engineering of the electronics.
Dr. Raj Attariwala commented, “This version of the smaller FAIMS cell and its critical reduction in power supply requirements with maintained THC sensitivity is a key step forward in preparing for field testing”.
Kal Malhi, President, commented, “Cannabix is moving quickly towards launching our FAIMS based Cannabix Marijuana Breathalyzer and completing external testing. With up to nine states in the US voting on marijuana legalization measures this fall, the need for a marijuana breathalyzer is becoming ever critical and we believe our timing for external testing of the Cannabix Marijuana Breathalyzer will coincide with further states legalizing marijuana.”
Disclaimer:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
